Attached files
file | filename |
---|---|
EXCEL - IDEA: XBRL DOCUMENT - INFINITY PHARMACEUTICALS, INC. | Financial_Report.xls |
EX-31.1 - CERTIFICATION OF PEO AND PFO PURSUANT TO SECTION 302 - INFINITY PHARMACEUTICALS, INC. | d262279dex311.htm |
EX-32.1 - CERTIFICATION OF PEO AND PFO PURSUANT TO SECTION 906 - INFINITY PHARMACEUTICALS, INC. | d262279dex321.htm |
EX-21.1 - SUBSIDIARIES OF THE REGISTRANT - INFINITY PHARMACEUTICALS, INC. | d262279dex211.htm |
10-K - FORM 10-K - INFINITY PHARMACEUTICALS, INC. | d262279d10k.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statements (Form S-3 Nos. 333-173534 and 333-156246, and Form S-8 Nos. 333-167488, 333-164207, 333-156641, 333-151135, 333-145306 and 333-138248) of Infinity Pharmaceuticals, Inc. and in the related Prospectuses of our reports dated March 13, 2012, with respect to the consolidated financial statements of Infinity Pharmaceuticals, Inc., and the effectiveness of internal control over financial reporting of Infinity Pharmaceuticals, Inc., included in this Annual Report (Form 10-K) for the year ended December 31, 2011.
/s/ Ernst & Young LLP |
Boston, Massachusetts
March 13, 2012